Get the Stockscreener App
5.42
23.18%
1.02
Pre-market:
5.98
0.56
+10.33%
Jupiter Neurosciences Inc stock is traded at $5.42, with a volume of 238.26K.
It is up +23.18% in the last 24 hours and down -44.30% over the past month.
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
See More
Previous Close:
$4.40
Open:
$4.45
24h Volume:
238.26K
Relative Volume:
1.05
Market Cap:
$179.42M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-61.45
EPS:
-0.0882
Net Cash Flow:
-
1W Performance:
-9.06%
1M Performance:
-44.30%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.21
$5.60
1-Week Range:
$4.11
$6.04
52-Week Range:
$4.11
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Name
Jupiter Neurosciences Inc
Sector
Industry
Phone
(561) 406-6154
Address
1001 NORTH US HWY 1, JUPITER
Compare JUNS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
5.42 | 179.42M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Jupiter Neurosciences Inc Stock (JUNS) Latest News
Jupiter Neurosciences refocuses on NLRP3 inflammasome By Investing.com - Investing.com South Africa
Jupiter Neurosciences refocuses on NLRP3 inflammasome - Investing.com India
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials - GlobeNewswire
Jupiter Neurosciences announces focus on NLRP3 pathway in JOTROL trials - TipRanks
Jupiter Neurosciences Targets NLRP3 Inflammasome With JOTROL Platform for Alzheimer's Treatment - StockTitan
Jupiter Neurosciences Inc. (JUNS) reports earnings - Quartz
Jupiter Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Jupiter Neurosciences inks deal for Southeast Asia expansion By Investing.com - Investing.com Australia
Jupiter Neurosciences inks deal for Southeast Asia expansion - Investing.com
Jupiter Neurosciences adjusts CFO compensation - Investing.com
Greenridge sees upside in Jupiter Neurosciences stock By Investing.com - Investing.com Canada
Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Citeline News & Insights
Tesla, Nvidia among Tuesday's market cap stock movers - Investing.com
Tesla, Nvidia among Tuesday's market cap stock movers By Investing.com - Investing.com UK
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Marvell, Credo Tech lead Friday's market cap stock movers By Investing.com - Investing.com South Africa
Marvell, Credo Tech lead Friday's market cap stock movers - Investing.com India
Adobe, Ciena lead Thursday's market cap stock movers By Investing.com - Investing.com South Africa
Adobe, Ciena lead Thursday's market cap stock movers - Investing.com
Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On ThursdayAkso Health (NASDAQ:AHG), Bloom Energy (NYSE:BE) - Benzinga
Opening Day: Jinxin Technology, zSpace make public debut - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
IPO NewsUS IPO Weekly Recap: ServiceTitan launches as small issuers slip through the IPO window - Renaissance Capital
Rx Rundown: Eli Lilly, Amgen, GSK and more - MM+M Online
Company behind novel Parkinson's disease treatment raises $11 million in IPO - The Business Journals
Jupiter IPOs to advance resveratrol-based treatments for neuroinflammation - Longevity.Technology
Grupo Aeroportuario del Pacifico Reports in November 2024 a Passenger Traffic Increase of 1.8% Compared to 2023 - The Manila Times
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering - GlobeNewswire
Jupiter Neurosciences Launches $11M IPO to Advance Parkinson's Disease Treatment Pipeline - StockTitan
Sumitomo Chemical Transfers Subsidiary Shares to GE HealthCare - MSN
IPO Roundup: Fast Track Group, MasterBeef and more - MSN
G50 Corp to Present at Sydney Investor Conference - MSN
Gildan Activewear, Inc. (GIL) Hit a 52 Week High, Can the Run Continue? - MSN
Aclaris Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - MSN
Tri Chemical Laboratories Reports Strong Financial Gains - MSN
Broadridge Stock Rises 11% in a Month: What You Should Know - MSN
Arteris, Inc. (AIP) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Dragon Rise Group Reports Revenue Surge, Holds Dividends - MSN
Apollo’s Novolex Explores Offer for Pactiv Evergreen - MSN
Jupiter Neurosciences stock rallies 37% following $11M IPO - MSN
2024's 10 Best-Performing Stocks - MSN
Why Accenture Stock Slumped Today - MSN
Agenus (AGEN) Stock Drops 5.50% Amid Biotech Sector Decline - GuruFocus.com
Morgan Stanley Upgrades Axon Enterprise (AXON) - MSN
Porch Stock Rockets After Firm Announces Upbeat Financial Targets Ahead Of Investor Day: Retail Sentiment Soars - MSN
Fastly price target raised to $10 from $8 at Piper Sandler - MSN
JUNS IPO NewsNeuro-inflammation biotech Jupiter Neurosciences prices IPO at $4, the low end of the range - Renaissance Capital
Don't Miss the Buying Opportunity in This Dividend King, Says Analyst - MSN
JUNSJUNS Latest Stock News & Market Updates - StockTitan
Jupiter Neurosciences Inc Stock (JUNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):